Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal
https://pubmed.ncbi.nlm.nih.gov/31912902Actively Recruiting
Led by Peking University First Hospital · Updated on 2025-06-03
1724
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are investigating the effects of goal-directed hemodynamic management on kidney injury in patients undergoing radical nephrectomy or nephroureterectomy, surgeries performed for renal cell carcinoma and upper tract urothelial carcinoma. These surgeries often lead to acute kidney injury (AKI), which increases the risk of chronic kidney disease (CKD). This study aims to determine if managing blood flow and pressure during surgery can reduce AKI occurrence and improve long-term kidney health. The study compares two approaches during surgery: one group receives goal-directed hemodynamic management involving active hydration, inotropes (dobutamine), and forced diuresis to maintain specific targets for pulse pressure variation, mean arterial pressure, and urine output. The other group receives routine care with standard fluid infusion and blood pressure targets. Post-surgery, blood pressure is carefully managed for 48 hours in the goal-directed group, while routine care continues for the other group. Participants will be monitored for up to 7 days after surgery to assess the incidence of acute kidney injury, and for up to 2 years to evaluate new or worsening chronic kidney disease. Additional outcomes include heart injury, delirium, surgical site infections, and survival without major events. The study involves regular monitoring of vital signs, kidney function, and other health assessments during hospitalization and follow-up visits to evaluate the long-term effects of the different management approaches.
CONDITIONS
Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and first 48 hours after surgery
Participants undergo radical nephrectomy or nephroureterectomy surgery. During anesthesia, participants receive either targeted hemodynamic management involving active hydration, inotropes, and forced diuresis to maintain specific blood pressure and urine output targets, or routine care according to standard practice. Hemodynamic management continues during the first 48 hours after surgery.
1 surgical visit and hospital stay including post-operative care
Duration - Up to 2 years after surgery
Participants are monitored for acute kidney injury, myocardial injury, delirium, and surgical site infections following surgery. Kidney function and possible chronic kidney disease progression are assessed over time.
Visits up to 7 days, 30 days, 3 months, and periodic assessments up to 2 years
Total: 1 location
1
Beijing University First Hospital
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
D
Dong-Xin Wang, MD,PhD
Q
Qiongfang Wu, MD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal
https://pubmed.ncbi.nlm.nih.gov/31912902Tobias Klatte, Sabrina H Rossi, Grant D Stewart
https://pubmed.ncbi.nlm.nih.gov/29713755Ajin Cho, Jung Eun Lee, Gee-Young Kwon...
https://pubmed.ncbi.nlm.nih.gov/21406544Carlo Garofalo, Maria Elena Liberti, Domenico Russo...
https://pubmed.ncbi.nlm.nih.gov/29063267Sung Shin, Youngjin Han, Hojong Park...
https://pubmed.ncbi.nlm.nih.gov/23591189Lakhmir S Chawla, Paul W Eggers, Robert A Star...
https://pubmed.ncbi.nlm.nih.gov/24988558Emily J See, Kushani Jayasinghe, Neil Glassford...
https://pubmed.ncbi.nlm.nih.gov/30473140Alparslan Turan, Barak Cohen, Janet Adegboye...
https://pubmed.ncbi.nlm.nih.gov/31929326Won Ho Kim, Kyung Won Shin, Sang-Hwan Ji...
https://pubmed.ncbi.nlm.nih.gov/32106477Michael Walsh, Philip J Devereaux, Amit X Garg...
https://pubmed.ncbi.nlm.nih.gov/23835589